From: Impact of uterine contractility on quality of life of women undergoing uterine fibroid embolization
Inclusion criteria | |
• Women aged 25–45 years with symptomatic fibroids and indications for embolization undergoing UFE | |
• MRI performed up to 30 days before UFE and up to 6 months after UFE | |
Non-inclusion criteria | |
• Patients on hormonal blockade (GnRH analogues) | |
• Changes in hormone profile suggestive of menopause | |
• Exclusively submucosal or subserosal fibroids | |
• Patients undergoing fertility therapies or assisted reproduction techniques (in vitro fertilization, intracytoplasmic sperm injection, intrauterine insemination) | |
Exclusion criteria | |
• Fibroids with radiological signs predictive of UFE failure, such as calcifications and absence of vascularization | |
• Clinical or radiological suspicion of malignancy | |
• Refusal to participate |